Myelination of axons in the CNS by oligodendrocytes is a process critical to rapid and efficient impulse conduction. A new role for the myelin proteolipid protein (PLP), the most abundant protein of CNS myelin, has been identified, in studies showing PLP interaction with signaling proteins in oligodendrocytes. In particular, these studies suggest that the PLP protein may be involved in signaling through integrins in oligodendrocytes. Stimulation of muscarinic acetylcholine receptors on oligodendrocytes induced formation of a tripartite complex containing PLP, calreticulin, and ␣ v -integrin. PLP interacted directly with the cytoplasmic domain of the ␣ v -integrin. Complex formation was mediated by phospholipase C and Ca 2ϩ binding to the high affinity binding site on calreticulin. This complex appears important for binding of fibronectin to oligodendrocytes. These data establish a novel function for PLP as a part of the integrin signaling complex in oligodendrocytes and suggest that neurotransmitter-mediated integrin receptor signaling may be involved in myelinogenesis.
The myelin proteolipid protein (PLP) and its alternatively spliced isoform DM20 are transmembrane proteins that constitute ϳ50% of the protein in myelin (Eng et al., 1968; Lees and Brostoff, 1984) . Despite the fact that PLP was identified more than 50 years ago (Folch and Lees, 1951) and it is an extremely abundant protein, no clear physiological role for this protein has been identified, although ionophoric activities have been proposed (Ting-Beall et al., 1979; Lees, 1982, 1984; Helynck et al., 1983; de Cozar et al., 1987; Diaz et al., 1990) . In general, it has been assumed to function as a structural component of myelin, providing stability and maintaining the compact lamellar structure of myelin.
The current studies were initiated to investigate whether, in addition to its structural functions, PLP might be involved in signal transduction in oligodendrocytes. Thus, we investigated what proteins PLP interacts with and what consequences these interactions might have. PLP has four transmembrane domains with both N-and C-termini facing the cytosol (Popot et al., 1991; Weimbs and Stoffel, 1992; Gow et al., 1997) . This tetraspan structure is distantly related to the tetraspanin family of proteins, which appears to be involved in signal transduction via interaction with integrin receptors (Maecker et al., 1997) . A major function of integrins is to provide a physical connection between extracellular matrix (ECM) proteins and intracellular cytoskeletal-signaling molecules (Ruoslahti, 1996; Liu et al., 1999; Coppolino and Dedhar, 2000) , including calreticulin (CRT), a multifunctional Ca 2ϩ -binding protein (Michalak et al., 1999) . Integrins are involved in signaling from the extracellular milieu into the cell, which is termed outside-in signaling, and their ligand binding activity can be modulated by intracellular signals, which is termed inside-out signaling. Inside-out signaling through integrins can originate from diverse plasma membrane receptors, including muscarinic acetylcholine receptors (mAChRs). Both oligodendrocyte progenitors and myelinating oligodendrocytes are intimately associated with axons, suggesting the existence of neuronal signals affecting oligodendrocyte proliferation, migration, and differentiation (Levine, 1989; Notterpek and Rome, 1994; Barres and Raff, 1999) . Although oligodendrocytes can differentiate without neurons, axons or axon-derived signals enhance myelin protein expression (Macklin et al., 1986; Kidd et al., 1990; Scherer et al., 1992) . Axonal signals may also be required for oligodendrocyte survival (Barres and Raff, 1993) , and it has been suggested that neuronal electrical activity is linked to myelinogenesis, perhaps by stimulating the release of growth factors and neurotransmitters from axons or from astrocytes or other glial cells (Barres and Raff, 1993; Demerens et al., 1996; Bergles et al., 2000) . In addition, neurotransmitter receptors are expressed by oligodendrocytes at several stages of differentiation, which suggests that they might participate in oligodendrocyte differentiation (Belachew et al., 1999) .
The current studies demonstrate that PLP may be involved in signaling through integrins and CRT, after mAChR activation in oligodendrocytes. Thus, agonist stimulation of the mAChR on oligodendrocytes is accompanied by a significant increase in a tripartite complex consisting of PLP, CRT, and ␣ v -integrin receptor, and this complex formation appears to modulate binding of ECM proteins to oligodendrocytes. Molecular details of these interactions and their consequences are presented. This is the first study to demonstrate an active role for PLP in signaling within the oligodendrocyte, and it suggests that PLP may be involved in neurotransmitter-induced adhesion events resulting from the neuron-oligodendroglial communication network.
NHS-SS-biotin in PBS for 30 min at room temperature. Unreacted biotin was removed by washing three times with ice-cold PBS. C ell lysates were immunoprecipitated with anti-PL P antibody (1:50). Antigen -antibody complexes were captured with Dynabeads. Immunocomplexes were eluted from the Dynabeads by incubating with 10 mM DTT in PBS for 3.5 hr at 37°C. To separate biotinylated proteins, 0.75 ml of the sample was applied to 0.3 ml of 50% slurry of neutravidin beads, which had been washed with PBS. The mixture was incubated at 4°C ON with rotation. Biotinylated proteins were eluted by boiling Dynabeads in SDS sample buffer.
To cross-link cell surface proteins, cells were incubated for 30 min at 22°C in PBS, pH 8.0, containing 0.5 mM DTSSP. Cross-linking reaction was stopped with 50 mM Tris/ HC l, pH 7.4. C ells were washed three times with PBS and solubilized in lysis buffer supplemented with protease inhibitors. Samples were analyzed by immunoprecipitation and Western blot. Samples were analyzed on reducing and nonreducing gels. On nonreducing gels, cross-linked proteins will comigrate. However, the DTSSP disulfide bond is cleaved by reducing agent, and the cross-linked proteins migrate at their native size on the gel in reducing gels.
Peptide synthesis, purification, and immobilization. Peptides were synthesized as described (Vinogradova et al., 2000) . Briefly, peptides were synthesized on 4-methylbenzhydrylamine resins (␣-carboxamides) or on appropriate Boc-aminoacyl-OCH 2 -Pam resins (carboxylates). The synthesis followed a manual stepwise in situ neutralization -activation protocol using tert-butyloxycarbonyl (Boc) protection, monitoring coupling efficiency by quantitative ninhydrin method. Myristoylation of the N terminus of peptides was performed with myristic acid and 1,3-diisopropylcarbodiimide (1:0.95 mol:mol) in a mixture of dichloromethane:dimethylformamide (4:1, vol / vol), following standard solution methods. Synthetic peptides were cleaved from the resin and deprotected by hydrofluoric acid, extracted into aqueous acetic acid, then purified by C18 reverse-phase HPLC. The purity of each peptide was confirmed to be Ͼ98%, as assessed by analytical HPLC and mass-spectroscopy.
To prepare immobilized peptide, cysteine was added to the N terminus of non-myristoylated peptides, and then peptides (10 mg) were dissolved in 50 mM Tris, 5 mM EDTA, pH 8.5, and coupled to resin by incubating ON with 2 ml of SulfoLink resin (Pierce, Rockford IL). Percentage of coupling was Ͼ99%, as assessed by using Ellman's reagent. C ysteine alone was used for the control column. Equal amounts of cell lysate were passed through each column twice, then the columns were extensively washed with PBS to remove all unbound material. The proteins bound to the column were eluted with a buffer containing 0.5 M NaC l, 0.1 M glycine, pH 3.0, 0.05% Triton X-100, and 0.01% SDS and analyzed by Western blotting.
Fibronectin binding assay. Fibronectin or BSA was labeled with Alexa Fluor 488 fluorescent dye using a protein labeling kit (Molecular Probes, Eugene, OR) according to the manufacturer's instructions. A fibronectin binding assay was performed, as described in Vinogradova et al. (2000) . Briefly, enriched oligodendrocytes, grown in 96-well microtiter plates (Corning Costar Corp., C ambridge, M A), were incubated with 50 M RGDS peptide or antibodies (1:100) for 30 min at 37°C and 5% C O 2 , stimulated with 2 mM Ca 2ϩ and /or 100 M carbachol for 10 min. Then, 10 g / well fibronectin-Alexa Fluor 488 conjugate was added, and the incubation continued for 30 min. Control experiments using BSA-Alexa Fluor 488 conjugate were done identically. C ells were washed twice with PBS. Fluorescence in each well was measured at 530 nm with 480 nm excitation using a C ytoFluor Multiwell Plate Reader (PerSeptive Biosystems). Replicates of three to six wells of cells were used in each experiment, and multiple experiments were averaged. Data from the binding assays are expressed as mean Ϯ SEM. Differences were compared by one-way ANOVA and Student-Newman -Keuls post hoc test. Means were considered to be significantly different when p Ͻ 0.05.
RESULTS

PLP exists in a complex with the ␣ v integrin receptor
Integrins exist as heterodimers of ␣ and ␤ subunits, which are transmembrane glycoproteins. To investigate whether PLP exists in a complex with integrin receptors, we conducted coimmunoprecipitation experiments from differentiated oligodendrocytes in mixed glial culture using antibodies to various integrin receptor ␣-subunits. Western blots were probed with antibody directed against the C terminus of PLP, which can recognize both PLP and DM20. In oligodendrocytes, PLP coimmunoprecipitated with ␣ v -integrin ( Fig. 1 A) but did not coimmunoprecipitate with control IgG or ␣ 6 -integrin, which is another ␣-integrin expressed by oligodendrocytes. Additionally, it did not coimmunoprecipitate with ␣ 1 -integrin, which is not expressed in oligodendrocytes, but rather in astrocytes (Tawil et al., 1994) , which are abundant in the mixed glial cultures. These data demonstrated that PLP interaction with integrin was specific for the ␣ v -integrin present in oligodendrocytes. There was no ␣ v -integrin association with MBP or MOG, which are other myelin proteins expressed by differentiated oligodendrocytes (Fig. 1 A) . To confirm that this interaction was not a culture artifact, we analyzed brain homogenates; PLP also coimmunoprecipitated with ␣ v -integrin receptor from brain ( Fig. 1 A) . In contrast, DM20 was not detected in immunoprecipitates from either cultured oligodendrocytes or brain. To assess whether the localization of ␣ v -integrin in brain brought it into proximity of PLP, we analyzed its expression in compact myelin, where PLP is localized. The ␣ v -integrin was found in compact myelin (Fig. 1 A) , where it was, in fact, enriched relative to whole brain lysate.
To confirm the PLP association with ␣ v -integrin, the reciprocal coimmunoprecipitation experiments were performed. PLP antibody immunoprecipitated ␣ v -integrin from the oligodendrocyte lysate (Fig. 1 B) and from whole brain lysate (data not shown). To determine which integrin receptor is associated with PLP, the immunoprecipitates were tested with antibodies directed against the ␣-subunits (␣ 1 and ␣ 6 ) present in mixed glial cultures and ␤-subunits (␤1, ␤3, ␤5, and ␤8) expressed in oligodendrocytes (Milner and ffrench-Constant, 1994) . PLP coimmunoprecipitated specifically with ␣ v ␤5 integrin (Fig. 1 B) , but not other ␤-integrins. The association of CRT with PLP was also studied, because it is known to bind to the cytoplasmic domain of the ␣ v -integrin (Rojiani et al., 1991) ; there was a clear association of PLP with CRT ( Fig. 1 B) . Thus, in oligodendrocytes, PLP associated with both CRT and ␣ v ␤5 integrin receptor. Neither CNP nor MOG-specific antibody precipitated CRT, and although MBP antibody immunoprecipitated CRT (Fig. 1C) , it was not detected in the immunoprecipitate with the ␣ v -integrin and PLP (Fig. 1 A) . Thus, although there may be an association of MBP with CRT in oligodendrocytes, it is not part of the complex with ␣ v -integrin, CRT and PLP. Taken together, these data suggest that PLP can form a unique tripartite complex with CRT and ␣ v ␤5 integrin in differentiated oligodendrocytes.
CRT exists in a complex with PLP at the cell surface Both PLP and ␣ v ␤5 integrin are integral membrane proteins localized at the plasma membrane, suggesting that the complex of PLP, ␣ v ␤5 integrin and CRT may exist at the surface of oligodendrocyte. However, CRT has well recognized physiological roles in the endoplasmic reticulum (ER) as a molecular chaperone and Ca 2ϩ -signaling molecule (Michalak et al., 1999) . On the other hand, recent data suggest that despite the presence of a KDEL sequence, i.e., an ER retention signal, CRT can also be found at the surface of cells, such as in the neuronal cell line NG-108 -15 (Johnson et al., 2001) . To examine whether CRT was localized at the plasma membrane in oligodendrocytes, cell surface proteins were cross-linked using the membrane-impermeable cross-linking reagent (DTSSP), and subsequently immunoprecipitated with PLP antibody (Fig. 2 A,B) . Because DTSSP is a cleavable cross-linking reagent, the cross-linking disulfide bond is cleaved by reducing agent in the sample buffer, and the crosslinked proteins migrate at their native size on the gel. The amount of CRT in the PLP immunoprecipitate (reducing gel) increased after cross-linking, suggesting that CRT may be at the surface of the oligodendrocyte in close proximity to PLP, and that after cross-linking, more is associated with PLP ( Fig. 2 A) . There was no MBP detected in the immunoprecipitates. Because MBP is also at the plasma membrane, but on the cytoplasmic surface, this is consistent with the cell surface impermeance of DTSSP, and the specificity of the PLP-CRT interaction at the cell surface. The PLP immunoprecipitate was also analyzed on nonreducing gel (Fig. 2 B) . As expected, both CRT and PLP co-migrated as a higher molecular weight protein complex after cross-linking. As another approach to confirm the cell surface localization of this interaction, surface proteins were biotinylated, and biotinylated proteins from a PLP immunoprecipitate were purified using neutravidin beads (Fig. 2C ). PLP antibody precipitated biotinylated CRT, supporting the concept that CRT could Cell lysates were immunoprecipitated with control IgG (1:100), ␣ 1 -integrin antibody (1: 100), ␣ v -integrin antibody (1:100), or ␣ 6 -integrin antibody (1:100). Immunoprecipitates and cell lysate (8 g) or brain lysate (2 or 4 g) were loaded onto SDS-polyacrylamide gel and analyzed by Western blots using PLP antibody, which recognizes both PLP and DM20 (1:100), MBP antibody (1:500), or MOG antibody (1: 200). Whole rat brain lysate (5 g) and purified myelin (5 g) samples were analyzed by SDS-PAGE and Western blotting using polyclonal ␣ v -integrin antibody (1:100) (bottom right panel ). B, Coimmunoprecipitation of ␣ v ␤5 integrin with PLP and CRT from oligodendrocytes in mixed glial cultures. Cell lysates were immunoprecipitated with PLP antibody (1:50), and then analyzed by Western blots along with aliquots of lysate (5g) using ␣ v antibody (1:100), ␣ 6 antibody (1:200), ␣ 1 antibody (1:100), ␤1 antibody (1:100), ␤3 antibody (1:200), ␤5 antibody (1:100), ␤8 antibody (1:200), or CRT antibody (1:100). C, Coimmunoprecipitation of CRT with PL P or MBP from oligodendrocytes in mixed glial cultures. C ell lysates were immunoprecipitated with MOG, C N P, PL P, or MBP antibody (1:50) and analyzed on Western blots with CRT antibody (1:100). Lysate samples were 3 g. form a complex with PLP and ␣ v ␤5 integrin receptor at the oligodendrocyte plasma membrane.
Further confirmation of the surface expression of CRT in oligodendrocytes was obtained by staining live cells. Thus, mixed glial cells were incubated with antibodies against CRT and PLP. Incubation with antibody against the C terminus of PLP did not stain live cells, although it did stain fixed cells (data not shown). On the other hand, oligodendrocytes in the mixed cultures stained with antibody for a surface epitope of PLP, the C-D loop, and with antibody against CRT (Fig. 3) . Clearly both PLP and CRT were detectable at the surface of oligodendrocytes, and there appeared to be some colocalization of signal.
Stimulation of mAChR triggers formation of a tripartite complex
It has been shown that integrins represent downstream effectors of mAChRs and that integrin activation in response to mAChR stimulation results in focal adhesion formation in human embryonic kidney (HEK) cells (Slack, 1998) . Because oligodendrocytes express m1, m2, and m3 mAChRs (Cohen and Almazan, 1994; Simpson and Russel, 1996) , we tested the physiological significance of the PLP association with the integrin receptor and CRT by studying formation of the tripartite complex after agonist stimulation of mAChR. Analysis of the carbachol effect on the formation of the PLP/CRT/␣ v integrin complex revealed a timedependent increase in the CRT and ␣ v -integrin association with PLP (Fig. 4 A) . Comparable results were obtained for oligodendrocytes shaken and purified from mixed glial cultures, indicating that the mAChRs on the oligodendrocytes themselves were responsible for the response, not those on astrocytes in the mixed glia (Fig. 4 B) . The increase in binding of both CRT and ␣ vintegrin was maximal after 10 min treatment with carbachol and declined somewhat by 20 min. Preincubation of the cells with 20 M atropine, a potent mAChR antagonist, reduced the carbacholinduced response at 10 min. To further test the specificity of the PLP and ␣ v ␤5 interaction, the PLP immunoprecipitates from carbachol-treated mixed glial cultures were analyzed for the presence of the other ␣-subunits and ␤-subunits present in these cultures. PLP did not interact with ␣ 1 , ␣ 6 , ␤1, ␤3, or ␤8 in cells treated with carbachol for 10 min (data not shown).
Two forms of ␣ v -integrin precipitated with PLP: a band migrating at 165 kDa protein and another band migrating at 150 kDa protein, which corresponded to the predominant form of the ␣ v -integrin in the lysate. It has been established that many ␣-integrin precursors, including ␣ v -integrin, undergo a posttranslational endoproteolytic cleavage in the membrane-proximal extracellular region (Delwel et al., 1996) . Thus, the 165 kDa protein is likely the ␣ v -integrin precursor, whereas the 150 kDa band represents the cleaved ␣ v -integrin. PLP association with the putative uncleaved ␣ v -integrin precursor was somewhat increased by carbachol treatment, but more strikingly, there was a dramatic time-dependent increase in PLP association with the classical ␣ v -integrin after carbachol stimulation of mAChR, and this was prevented by atropine. CRT forms a complex with PLP at the cell surface. A, Cell surface proteins were cross-linked with DTSSP, as described in Materials and Methods. Cell lysates were immunoprecipitated with control IgG (1:100) or PLP antibody (1:50). Control cell lysates (Con, 3 g), DTSSPcross-linked cell lysates (DP, 3 g), and immunoprecipitates from equal amounts of the lysate were loaded onto SDS-polyacrylamide gel containing reducing agent, and then analyzed by Western blots using CRT antibody (1:100) or MBP antibody (1:500). B, The PLP immunoprecipitates from control cells and after cross-linking with DTSSP were eluted in nonreducing sample buffer and loaded onto nonreducing SDSpolyacrylamide gels. Samples were analyzed by Western blotting first with CRT antibody (1:100, left panel ), then the blot was stripped and re-probed with PLP antibody (1:100, right panel ). Note co-migrating band. C, Biotinylation of cell surface proteins was performed on mixed glial cultures, as described in Materials and Methods. Cell lysate (3 g) and equal amounts of immunoprecipitated protein samples bound to neutravidin beads were loaded onto the gel and analyzed by Western blots using PLP antibody (1:100) and CRT antibody (1:100). 
Direct interaction of PLP with ␣ v -integrin
We next focused on defining the interactions of the proteins within the PLP/CRT/␣ v complex. The integrin receptor could interact directly with PLP or with CRT, which could, in turn, recruit PLP to the complex. To determine whether PLP interacted directly with the integrin receptor, we analyzed cells that were stimulated with carbachol in the presence of synthetic peptides mimicking the inactive and active forms of the cytosolic domain of the ␣ v -integrin receptor. TH110 is the full length C-terminal cytoplasmic domain of the ␣ v -integrin, and TH126 is the C terminus minus the terminal 10 amino acids (Fig. 5A) . The N terminus of the peptides is modified by myristoylation, which allows peptides to traverse the plasma membrane into cells and acts as a surrogate transmembrane domain that anchors proteins and domains onto the membrane surface, similar to the cytoplasmic domains of intact receptors (Vinogradova et al., 2000) . The current conformation-based model for integrin activation, as determined by nuclear magnetic resonance (Vinogradova et al., 2000) , suggests that the full-length nonactivated cytoplasmic tail of ␣ v -integrin is in a "closed" conformation, whereas the N-terminal membrane-proximal region forms an ␣-helix followed by a turn. The structure of the shorter, activated ␣ v cytoplasmic domain is significantly different, having an "open" conformation. Thus, full-length TH110 is likely to be in a closed nonactivated conformation, unable to compete with the activated native fulllength cytoplasmic domain of the ␣ v cytoplasmic tail in open conformation. In contrast, the shorter peptide, TH126, should act as a competitive inhibitor.
We tested whether these peptides could serve as competitive inhibitors of the PLP interaction with the integrin receptor. Treatment of oligodendrocytes with full-length peptide TH110 had no effect on the interaction of PLP with ␣ v -integrin or with CRT, after carbachol treatment (Fig. 5B) . By contrast, the truncated peptide (TH126) caused a significant depletion of the ␣ v -integrin in the PLP immunoprecipitate. Thus, it blocked the interaction of these two proteins, suggesting that PLP interacts directly with the cytoplasmic domain of the ␣ v -integrin. In the presence of TH126, CRT was also no longer associated with PLP. Thus, preventing PLP interaction with activated ␣ v -integrin blocked the interaction of PLP and CRT, suggesting that CRT is associated with PLP by binding to ␣ v -integrin, which in turn binds to PLP, after mAChR stimulation of oligodendrocytes.
These studies strongly suggested that binding is directly between PLP and the cytoplasmic domain of activated ␣ v -integrin. We tested this further by studying whether PLP would bind to immobilized TH110 or TH126 (Fig. 5C ). Whereas CRT bound to M peptide in serum-free medium for 1 hr. Cells were then exposed to carbachol for 10 min, and lysates were prepared. Cell lysates were immunoprecipitated with control IgG (1:100) or PLP antibody (1:50) and analyzed by Western blotting using ␣ v -integrin antibody (1:100), CRT antibody (1:100), or PLP antibody (1:100). Lysate samples contained 5 g of protein (␣ v -integrin) or 3 g of protein (CRT, PLP). C, PLP and CRT binding to immobilized peptides. Cell lysate was passed through a control cysteine-linked column (Cys), a TH110 peptide-linked column, or a TH126 peptide-linked column. The columns were washed with PBS and eluted. Eluted proteins were analyzed by Western blotting using PLP antibody (1:100) or CRT antibody (1:100). Lysate samples contained 3 g of protein.
both TH110 and TH126, PLP selectively bound to TH126. Thus, only TH126 bound PLP in lysates and it competed for ␣ v -integrin association with PLP in oligodendrocytes. In conjunction with studies described below, which show that PLP can bind ␣ vintegrin in the absence of CRT, we conclude that PLP interacts directly with the C-terminal cytoplasmic domain of ␣ v -integrin in oligodendrocytes.
Carbachol-induced PLP association with ␣ v -integrin depends on PLC and intracellular Ca
2؉
The m1 and m3 mAChRs expressed by oligodendrocytes are functionally linked to PLC activation (Cohen and Almazan, 1994) . To determine whether the carbachol-induced formation of the tripartite complex was mediated by PLC, cells were pretreated with U73122 (a potent blocker of PLC) and then with carbachol. U73122 (20 M) completely abolished the PLP association with ␣ v -integrin and CRT (Fig. 6 A) . The inactive structural analog of this PLC inhibitor, U-73433 (20 M), did not affect complex formation. Thus, stimulation of mAChR triggered tripartite complex formation via activation of PLC in oligodendrocytes.
Activated PLC generates inositol 1,4,5-triphosphate (IP 3 ), which releases Ca 2ϩ from internal stores. In addition, carbachol stimulates extracellular Ca 2ϩ influx in fibroblasts by opening plasma membrane channels (Felder et al., 1992) . To determine whether Ca 2ϩ is required for carbachol-induced formation of the complex between PLP, CRT, and ␣ v -integrin, intracellular or extracellular Ca 2ϩ were depleted. Cells were loaded with 20 M BAPTA-AM (a cell-permeable Ca 2ϩ chelator) for 30 min, and then exposed to carbachol and analyzed for complex formation. The PLP-␣ v -integrin receptor interaction was unchanged, relative to control (Fig. 6 B) , indicating that the PLP association with ␣ v -integrin is independent of intracellular Ca 2ϩ . By contrast, there was a significant decrease in CRT associated with the complex. Because chelation of intracellular Ca 2ϩ blocked the carbachol-induced CRT association with the integrin receptor and PLP, it appears that the events triggered by mAChR stimulation depend on release of Ca 2ϩ from intracellular stores, but only with respect to the association of CRT with the complex. The carbachol-induced PLP interaction with ␣ v -integrin appears to be independent of intracellular Ca 2ϩ . To assess whether extracellular Ca 2ϩ was involved in carbachol-stimulated complex formation, cultures were preincubated with 5 mM EGTA to chelate extracellular Ca 2ϩ , and then treated with carbachol. Complex formation was unaffected by chelation of extracellular Ca 2ϩ (Fig.  6 B) , which implies that influx of extracellular Ca 2ϩ is not necessary for carbachol-induced CRT or PLP interaction with ␣ vintegrin receptor.
Because changes in intracellular Ca 2ϩ concentration impacted the association of CRT with the complex, we tested the amount of intracellular Ca 2ϩ that was important. CRT association with the integrin receptor can be modulated by Ca 2ϩ binding to either of two sites on CRT, a low-affinity (K d , 1-2 mM) or high-affinity site (K d , 1 M; Michalak et al., 1999) . To determine the Ca 2ϩ concentration required for CRT association with ␣ v -integrin receptor and PLP, cell samples were lysed in the presence of several Ca 2ϩ concentrations, and Ca 2ϩ concentration was kept constant throughout the subsequent immunoprecipitation experiment (Fig. 7) . A dramatic increase in CRT associated with PLP was seen when the Ca 2ϩ concentration was raised from 0 (in the presence of 5 mM EGTA) to 20 M, but no significant change was noted beyond that, up to 1 mM. These data suggest that carbacholinduced mobilization of Ca 2ϩ from intracellular stores, typically in this range of Ca 2ϩ concentration, results in Ca 2ϩ binding to the high-affinity site of CRT leading to increased association of CRT with ␣ v -integrin and PLP.
The PLP-␣ v -integrin-CRT complex binds ECM proteins
To determine whether CRT and PLP can modulate ␣ v ␤5 integrin interaction with extracellular ligand in oligodendrocytes, we mea- sured fibronectin binding to oligodendrocytes (Fig. 8) . Fibronectin is produced by cells in the ventricular zone and is distributed along radial glial processes in early cortical development (Pearlman and Sheppard, 1996) . Thus, it may play a role in early neuronal and glial migration and differentiation. Enriched oligodendrocyte cultures exhibited rather low binding of fibronectinAlexa 488 conjugate, unless the Ca 2ϩ concentration in the incubation medium was raised. Thus, although extracellular Ca 2ϩ was not required for the formation of the tripartite complex (Fig.  6 B) , it significantly enhanced fibronectin binding to the complex. Fibronectin binding was suppressed by RGDS peptide, which is a potent inhibitor of ␣ v ␤5 binding activity, indicating that the Ca 2ϩ -dependent fibronectin interaction with oligodendrocytes was mediated by the integrin receptor. In addition, fibronectin binding was suppressed by CRT antibody, suggesting that CRT might be involved in the binding or that CRT association with the integrin may modulate ligand binding. The combination of RGDS peptide and polyclonal anti-CRT antibody did not produce any further suppression of fibronectin binding. PLP antibody directed against C terminus, which is exposed to cytosol, did not affect fibronectin binding. However, PLP antibody specific for the extracellular C-D loop domain of PLP, which binds live oligodendrocytes (Fig. 3) , inhibited binding of fibronectin to oligodendrocytes, suggesting PLP involvement in modulation of the integrin-ligand interaction (Fig. 8) . Antibody against other oligodendrocyte-specific proteins, such as MOG and CNP, did not affect fibronectin binding (data not shown). There was no generic effect of rabbit IgG directed against an irrelevant antigen on ligand binding, nor was there binding of AlexaFluor 488-BSA conjugate to oligodendrocytes. Our data demonstrate that soluble ligand binding to integrin receptor on oligodendrocytes is stimulated by extracellular Ca 2ϩ and is influenced by the CRT and PLP association with the integrin receptor.
As noted above, mAChR stimulation enhances complex formation and the amount of activated ␣ v integrin in the complex. We therefore tested its effect on the ECM binding activities of oligodendrocytes, by measuring fibronectin binding to cells pretreated with 100 M carbachol for 10 min (Fig. 9A) . Surprisingly, ligand binding was slightly reduced in cells stimulated with carbachol plus Ca 2ϩ , compared with ligand binding in the presence of Ca 2ϩ alone; it was still sensitive to suppression by CRT antibody. However, Ca 2ϩ -dependent fibronectin binding was not inhibited by either RGDS peptide or PLP antibody, but rather stimulated in carbachol-treated oligodendrocytes. RGDS peptide and PLP antibody also stimulated Ca 2ϩ -independent fibronectin binding to oligodendrocytes treated with carbachol (Fig. 9B) . Thus, mAChR stimulation of oligodendrocytes resulted in substantial changes in the integrin receptor interaction with the ligand, presumably from conformational changes in the tripartite PLP-CRT-␣ v -integrin complex. . mAChR stimulation affects Ca 2ϩ -dependent ( A) and Ca 2ϩ -independent ( B) fibronectin binding to the integrin receptor in oligodendrocytes. Enriched oligodendrocyte cultures were preincubated for 30 min with RGDS peptide (50 M, RGD), or CRT antibody (1:100, Ab-CRT ), or PLP antibody specific for extracellular C-D loop (1:100, Ab-PLP). Cells were then treated with 2 mM Ca 2ϩ and 100 M carbachol (A, Ca ϩ CB) or with 100 M carbachol alone (B, CB) for 10 min, and the incubation continued for another 30 min in the presence of 10 g of fibronectin-Alexa Fluor 488 conjugate. Oligodendrocytes were washed with PBS, and the fluorescence was measured. Data presented are means Ϯ SEM (3-6 replicates from at least 3 independent experiments). Nonspecific binding of fibronectin to wells filled with medium was subtracted from all measurements. A shows the effects of carbachol on fibronectin binding in the presence of Ca 2ϩ ( # p Ͻ 0.05, compared with untreated control; *p Ͻ 0.05, **p Ͻ 0.01, compared with carbacholtreated control). In B, statistical significance (*p Ͻ 0.05) of fibronectin binding to oligodendrocytes was compared with carbachol-treated cells.
DISCUSSION
Our data demonstrate that agonist stimulation of mAChR on oligodendrocytes enhanced formation of a complex containing ␣ v ␤5 integrin receptor, CRT and PLP by direct interaction of PLP with the cytoplasmic domain of ␣ v -integrin in oligodendrocytes. Our studies provide, for the first time, molecular evidence for participation of PLP and CRT in signaling in oligodendrocytes, and we confirm and extend earlier studies suggesting that ␣ v ␤5 integrin is a critical modulator of oligodendrocyte maturation and myelin gene expression.
Role of integrins in oligodendrocyte differentiation
Integrin-mediated interactions influence many aspects of cell behavior, including cell morphology, migration, proliferation, and differentiation. Oligodendrocytes express a limited repertoire of integrins: ␣ 6 ␤1, ␣ v ␤1, ␣ v ␤3, ␣ v ␤5, and ␣ v ␤8 (Milner and ffrenchConstant, 1994) , which are likely involved in important adhesive events, perhaps during oligodendrocyte migration and myelination Milner, 1997 ). An essential role of ␤1 integrins in myelination has been demonstrated in elegant studies from the ffrench-Constant group (Relvas et al., 2001) . ␣ 6 ␤1 is expressed throughout development, but ␣ v integrins exhibit developmental regulation; oligodendrocyte differentiation is accompanied by a loss of ␣ v ␤1 and an upregulation of ␣ v ␤5 (Blaschuk et al., 2000) . ␣ v ␤1 integrin is involved in oligodendrocyte progenitor migration (Milner et al., 1996) , and it has been suggested that ␣ v ␤3 may regulate oligodendroglial cell proliferation (Blaschuk et al., 2000) . Oligodendrocytes appear to use ␣ v ␤3 and ␣ v ␤5 integrins for process extension ). Interestingly, treatment of oligodendrocytes with RGD synthetic peptide, which blocks ␣ v -integrin function, results in a substantial decrease in the mRNAs encoding several myelin proteins including MBP, CNP, and PLP in oligodendrocytes (Cardwell and Rome, 1988a,b) . In addition, blocking antibody against ␣ v ␤5 integrin dramatically reduces MBP expression in CG-4 cells transfected with ␣ v ␤5 integrin receptor, suggesting that signaling through ␣ v ␤5 integrin is critical to continued differentiation (Blaschuk et al., 2000) . PLP interaction specifically with ␣ v ␤5 integrin, which is upregulated in oligodendrocytes with the onset of terminal differentiation and the appearance of differentiation markers such as PLP and MBP, further suggests an important role of ␣ v ␤5 integrin in mature oligodendrocytes.
Selective PLP interaction with the integrin receptor, in the absence of DM20, supports the idea that PLP and DM20 have distinct roles in oligodendrocytes. It is noteworthy that PLP, but not DM20, is an inositol hexakisphosphate-binding protein and has been implicated in vesicular transport regulation in oligodendrocyte (Yamaguchi et al., 1996) . DM20 cannot replace PLP in CNS myelin of a knock-in mouse (Stecca et al., 2000) . In this knock-in mouse, wild-type levels of Plp gene expression were found, but the gene was modified to express only DM20. Although DM20 was incorporated into the functional compact myelin sheath, PLP was required to produce the normal myelin period and to confer long-term stability on the multilamellar membrane. Thus, clearly PLP, which contains a unique 35 amino acid segment on the cytoplasmic surface of the bilayer, has specific and essential interactions with proteins and lipids that DM20 does not.
Integrin signaling in oligodendrocytes
Integrin activation involves modulation of both ligand binding affinity and avidity modulation, which may reflect changes in lateral mobility and integrin clustering (Ginsberg et al., 1992; Humphries, 1996) . For example, vascular endothelial growth factor (VEGF) activates ␣ v -integrin function and induces enhanced cell adhesion, migration, and soluble ligand binding (Byzova et al., 2000) . In addition, selective recruitment of high-affinity ␣ vintegrins has been identified as a mechanism by which lamellipodia promote formation of new adhesions at the leading edge in cell migration (Kiosses et al., 2001 ). Acetylcholine and muscarinic receptor agonists modulate adhesive properties of many cells, for example, stimulating cell-substrate attachment and formation of intercellular junctions in keratinocytes (Grando, 1997) . mAChR stimulation of HEK cells results in activation of integrins which, in turn, transmits a signal inside and outside the cell, leading to phosphorylation of intracellular cytoskeletal proteins and clustering of extracellular domains of integrins to form focal adhesions (Slack, 1998) . Our data showing that PLC activity was required for PLP recruitment into the integrin signaling complex in oligodendrocytes are in line with previous observations that mAChRs transmit their signal via G-proteins of Gq family to activate PLC (Nathanson, 2000) . Our results strongly suggest that acetylcholine could mediate some neuron-oligodendrocyte interactions, which could be important regulators of myelination or oligodendrocyte function in the CNS.
Since the discovery of CRT as a minor Ca 2ϩ -binding protein of the sarcoplasmic reticulum, appreciation of its importance has grown, and it is now recognized to be a multifunctional protein that is associated with cellular responses in many ways. Only a few proteins have been reported to interact with the ␣-subunit of the integrin receptors, including paxillin (Liu et al., 1999) , CRT (Rojiani et al., 1991) , and PLP (this study). CRT binding to ␣-integrin has been proven to be critical for regulating integrinmediated cell adhesion in other systems. Our study highlights the participation of CRT in integrin-ligand interaction in oligodendrocytes. Our data clearly show the presence of CRT on the surface of oligodendrocytes (Figs. 2, 3) . However, data on CRT association with integrins show that it interacts with the cytoplasmic tail of the ␣ v -integrin (Rojiani et al., 1991) , and chelating intracellular Ca 2ϩ removes CRT from the PLP-integrin-CRT complex (Fig. 6 B) , suggesting an intracellular localization. This dichotomy is unresolved, but it has been proposed that two forms of CRT may exist, an endoCRT molecule localized on the intracellular surface of the plasma membrane and an ectoCRT molecule localized on the extracellular surface of cells (Zhu et al., 1997) . Thus, further characterization of the CRT associated with this complex is needed.
The functional consequences of mAChR activation in oligodendrocytes and of PLP association with the integrin complex are unclear. Before carbachol stimulation of oligodendrocytes, integrin binding to fibronectin is relatively consistent with known integrin activities (Fig. 8) . Thus, RGD peptide reduces binding of fibronectin. In addition, a series of antibodies reduces ligand binding, although this can be used at the present time only as a measure of the presence of these proteins in the complex, not to assess their role in binding fibronectin. Quite intriguingly, after carbachol stimulation of oligodendrocytes, the conformation of the complex clearly changes, such that fibronectin binding is quite different (Fig. 9) . CRT antibody binding reduces fibronectin binding, whereas PLP antibody and ␣v antibody (data not shown) actually increase fibronectin binding. These antibody studies are most likely detecting a conformational shift of the overall complex and are not a measure of the specific contribution of one protein.
Most remarkably, adding RGD peptide to carbachol-treated oli-godendrocytes actually enhanced fibronectin binding after carbachol stimulation of oligodendrocytes. This is inconsistent with the traditional concept of RGD function as a competitive inhibitor of ligand binding to the active site of integrins. However, such results have been obtained in other studies, where incubation of platelet lysates with RGD peptide was associated with increased ligand binding properties of ␣ IIb ␤ 3 integrin (Du et al., 1991) . In that study, it was shown that the peptide that activated ␣ IIb ␤ 3 integrin was binding to the same site that is normally inactivated by RGD binding. Thus, it is likely that a conformational shift in this complex after mAChR activation in oligodendrocytes alters ligand binding in a unique manner. This question is under further investigation.
The fact that mAChR stimulation caused PLP, but not DM20, association with the activated ␣ v -integrin strongly implicates PLP as a novel participant in the integrin receptor adhesion complex and signaling in oligodendrocytes. The PLP interaction with integrin is rather intriguing. As noted above, the only sequence difference between PLP and DM20 is a 35 amino acid segment in the cytoplasmic domain of PLP. Thus, the fact that only PLP interacts with the integrin receptor suggests that this domain of PLP may be important for the interaction. Because we have shown direct PLP binding to the C-terminal peptide of the cytoplasmic tail of the ␣ v -integrin, the interaction of PLP and ␣ v -integrin appears to occur between the cytoplasmic domain of PLP and the cytoplasmic tail of ␣ v -integrin. These data are consistent with earlier studies showing that intracellular events influenced the conformation and extracellular ligand binding affinity of integrins through their cytoplasmic domain (Ginsberg et al., 1992) . For example, the tight association of paxillin, which is an intracellular signaling adaptor protein that interacts with the cytoplasmic tail of ␣ 4, may regulate cellular function by modifying the kinetics of integrin signaling (Liu et al., 1999) . On the other hand, potential participation of the extracellular domain of PLP in the interaction remains to be investigated, because some integral membrane proteins such as PDGF-R␤ and VEGF-R2 have been reported to interact with integrins via their extracellular domain (Borges et al., 2000) .
Potential functions of PLP gene family members
The myelin PLP is the earliest identified member of a small family of membrane proteins, which includes DM␣, DM␤, and DM␥ (Kitagawa et al., 1993) . The other members of this family were initially identified as edge membrane antigen (EMA) (Baumrind et al., 1992) or M6 (Yan et al., 1993) , which were characterized as neuronal proteins that were involved in neurite outgrowth. These proteins are more closely related to DM20, rather than PLP, although because PLP is identical to DM20 except for its unique 35 amino acid cytoplasmic domain, there is a high degree of homology with PLP as well. EMA is localized on the surface of the leading edge of growth cones, where it has been proposed to mediate interactions with the extracellular environment. M6, apparently the same protein, is also localized to growth cones, and antibody directed against it blocks neurite extension in cultured neurons (Lagenaur et al., 1992) . Thus, it was proposed that this protein was involved in cell adhesion during neurite extension.
In early studies, PLP/DM20 was shown to induce sodiumdependent conductance in lipid bilayers (Ting-Beall et al., 1979) and act as a dicyclohexylcarbodiimide-inhibitable ion channel Lees, 1982, 1984) . Thus, it can act as a Na ϩ -, Ca 2ϩ -, or proton ionophore in liposomes (Helynck et al., 1983; de Cozar et al., 1987; Diaz et al., 1990) , but these activities have been very difficult to study in vivo. M6 is also localized on the apical surface of proximal renal tubules and the apical surface of the choroid plexus, which are sites of significant ion transport. Evolutionary studies have demonstrated that the proteins in this family contain a 100 amino acid domain, whose closest relatives appear to be segments within the ␣ subunit of the nAChR in Torpedo and the rat brain GluR (Kitagawa et al., 1993) , and it was suggested that these proteins may have evolved from proteins that were closely related to ligand-gated channels. Thus, it has been suggested that these PLP/DM20-related proteins may participate in ion transport.
As noted, several of the PLP gene family members are localized to growth cones. Other crucial proteins for growth cone function are integrins, which are important contact points for growth cones and the ECM (McKerracher et al., 1996) . Interaction of integrin receptors with substrate regulates calcium transients in growth cones, which in turn control substrate-dependent growth cone turning (Gomez et al., 2001) . It should be noted that PLP/DM20 has been shown to enhance Ca 2ϩ fluxes, possibly by means of a protein conformational change (Diaz et al., 1990) . Thus, the possibility exists that those proteins in the PLP/DM20 gene family that are localized in growth cones may participate in complexes with integrins and potentially also CRT. Our studies demonstrate that DM20 itself, which is more closely related to the other PLP/DM20 gene family members, does not interact with ␣ v ␤5. However, this integrin is present in mature cells, whereas DM20 is expressed to a greater extent in immature cells, which were not analyzed in this study. Thus, it will be important to assess whether it can interact with integrins present on more immature cells. As an intriguing concept, we would suggest that members of this PLP/DM20 protein family may participate in integrin signaling, in particular as regulated by Ca 2ϩ , in a number of cell types.
